Needham Investment Management LLC Grows Position in 908 Devices Inc. (NASDAQ:MASS)

Needham Investment Management LLC grew its stake in 908 Devices Inc. (NASDAQ:MASS) by 100.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 100,000 shares of the company’s stock after acquiring an additional 50,000 shares during the quarter. Needham Investment Management LLC’s holdings in 908 Devices were worth $347,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Vanguard Group Inc. lifted its holdings in 908 Devices by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 1,751,102 shares of the company’s stock valued at $13,221,000 after purchasing an additional 6,772 shares in the last quarter. Millennium Management LLC raised its position in shares of 908 Devices by 35.5% in the second quarter. Millennium Management LLC now owns 618,310 shares of the company’s stock valued at $3,184,000 after buying an additional 161,922 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of 908 Devices by 88.3% during the second quarter. Dimensional Fund Advisors LP now owns 245,176 shares of the company’s stock valued at $1,263,000 after buying an additional 114,987 shares during the period. Charles Schwab Investment Management Inc. boosted its position in 908 Devices by 14.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 220,477 shares of the company’s stock worth $765,000 after acquiring an additional 28,015 shares during the last quarter. Finally, Renaissance Technologies LLC grew its stake in 908 Devices by 79.4% in the 2nd quarter. Renaissance Technologies LLC now owns 195,500 shares of the company’s stock worth $1,007,000 after acquiring an additional 86,500 shares during the period. Institutional investors and hedge funds own 88.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on MASS shares. Leerink Partnrs cut 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th. Leerink Partners reissued a “market perform” rating and issued a $4.00 price target (down from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Finally, Stifel Nicolaus dropped their price objective on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th.

908 Devices Stock Down 8.0 %

MASS stock opened at $2.64 on Wednesday. 908 Devices Inc. has a 52 week low of $2.19 and a 52 week high of $12.51. The company has a market cap of $91.92 million, a price-to-earnings ratio of -1.49 and a beta of 0.92. The business has a fifty day simple moving average of $3.21 and a 200-day simple moving average of $4.37.

908 Devices Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.